Table 1.
Experiment (Figure #) |
Participants | Cell type | LPS dose (ng/mL) |
OT doses (pM) |
Pre-incubation with OT (min) |
Cytokine Measurement |
---|---|---|---|---|---|---|
1 (1) | Female | Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 0 | FACS (CD14+ /IL-6 +) |
Male | Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 0 | FACS (CD14+ /IL-6+) | |
2 (1) | Female | Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 0 | FACS (CD14+ /IL-6 +) |
Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 30 | FACS (CD14+ /IL-6 +) | ||
Female | Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 30 | FACS (CD14+ /IL-6 +) | |
Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 60 | FACS (CD14+ /IL-6 +) | ||
3 (1) | Male | Isolated PBMCs | 50 | 0, 1, 10, 100, 1000 | 30 | FACS (CD14+ IL-6 +) |
Female | Isolated PBMCs | 50 | 0, 1, 10, 100, 1000 | 30 | FACS (CD14+ IL-6 +) | |
4 (2) | Female | Monocytes (whole blood) | 50 | 0, 1, 10, 100, 1000 | 0 | ELISA (IL-6) |
Monocytes (whole blood) | 0.5 | 0, 1, 10, 100, 1000 | 0 | ELISA (IL-6) | ||
5 (3) | Male | Monocytes (whole blood) | 50 | 0, 1, 10, 100 | 30 | Meso Scale (TNFα, IL-6, IL-8, IL-1β) |
6 (2) | Male | Monocytes (whole blood) | 50 | 0, 0.1, 1, 10, 100, 1000, 10000 | 30 | ELISA (IL-6) |
Female | Monocytes (whole blood) | 50 | 0, 0.1, 1, 10, 100, 1000, 10000 | 30 | ELISA (IL-6) | |
Female | Monocytes (whole blood) | 50 | 0, 0.1, 1, 10, 100, 1000, 10000 | 30 | ELISA (IL-6) | |
7 (2, 4) | Male | Macrophages | 50 | 0, 0.1, 10, 100, 1000 | 0 | ELISA (TNFα); Mesoscale (TNFα, IL-6, IL-8, IL-1β) |
Male | Macrophages | 50 | 0, 0.1, 10, 100, 1000 | 30 | ELISA (TNFα); Mesoscale (TNFα, IL-6, IL-8, IL-1β) | |
Male | Macrophages | 50 | 0, 0.1, 10, 100, 1000 | 0 | Mesoscale (TNFα, IL-6, IL-8, IL-1β) | |
Male | Macrophages | 50 | 0, 0.1, 10, 100, 1000 | 30 | Mesoscale (TNFα, IL-6, IL-8, IL-1β) |